Using Kaplan-Meier survival curve and log-rank analysis showed that patients whose tumor loss of ADAMTS2 showed significantly shorter cancer survival than those whose tumors expressed ADAMTS2. This evidence concerns the gene ADAMTS2 and neoplasm.